-56.6%
CRWV vs MRNA
+907.1%
-963.7%
-68.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +6.3% | +5.3% | +1.0% | +6.1% |
| 7D | -15.4% | +14.6% | -30.1% | -15.7% |
| 30D | -47.5% | +29.4% | -76.9% | -47.8% |
| 3M | -45.6% | +371.9% | -417.6% | -49.7% |
| 6M | -66.4% | +421.0% | -487.4% | -70.4% |
| YTD | -35.2% | +762.0% | -797.2% | -53.3% |
| 1Y | -56.6% | +944.8% | -1,001.4% | -68.8% |
| All | -56.6% | +907.1% | -963.7% | -68.8% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling